Franklin Resources Free cash flow decreased by 100.0% to $0.00 in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $488.40M to $0.00. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $178.90M | $461.70M | $149.70M | $78.30M | $806.70M | $831.70M | -$283.70M | -$88.70M | $575.60M | $737.20M | -$271.40M | $94.90M | $482.30M | $488.40M | -$217.00M | -$87.60M | $1.27B | $0.00 |
| QoQ Change | — | +158.1% | -67.6% | -47.7% | +930.3% | +3.1% | -134.1% | +68.7% | +748.9% | +28.1% | -136.8% | +135.0% | +408.2% | +1.3% | -144.4% | +59.6% | >999% | -100.0% |
| YoY Change | — | — | — | — | +350.9% | +80.1% | -289.5% | -213.3% | -28.6% | -11.4% | +4.3% | +207.0% | -16.2% | -33.7% | +20.0% | -192.3% | +162.9% | -100.0% |